Browse All

Current Filters

CLEAR FILTER x

TITLE

MRI, Efficacy, and Safety of Tolebrutinib in Patients with Highly Active Disease (HAD): 2-Year Data from the Phase 2b Long-term Safety (LTS) Study

Author:Fox, Robert   Oh, Jiwon   Arnold, Douglas   Syed, Sana   Xu, Zhixing   Turner, Timothy   Traboulsee, Anthony   Reich, Daniel   

Session Name:P6: MS Clinical Trials  

Topic:MS and Inflammatory Disease  

Program Number:P6.017  

Author Institution:Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH  St Michael's Hospital, University of Toronto, Toronto, ON, Canada  NeuroRx Research and Montréal Neurological Institute, McGill University, Montreal, QC, Canada  Sanofi, Cambridge, MA  Sanofi, Bridgewater, NJ  University of British Columbia, Vancouver, BC, Canada  National Institute of Neurological Disorders and Stroke, Bethesda, MD  

Myelin Water Fraction of Slowly Evolving Lesions is Associated With Disability in Multiple Sclerosis

Author:Zhuang, Rebecca   Vavasour, Irene   Elliott, Colm   Arnold, Douglas   Clayton, David   Magon, Stefano   Bonati, Ulrike   Bernasconi, Corrado   Gaetano, Laura   Traboulsee, Anthony   Kolind, Shannon   

Session Name:P10: MS Neuroimaging 1  

Topic:MS and Inflammatory Disease  

Program Number:P10.017  

Author Institution:University of British Columbia, Vancouver, BC, Canada  NeuroRx Research, Montreal, QC, Canada  Montreal Neurological Institute, McGill Univ, Montreal, QC, Canada  Genentech Inc, South San Francisco, CA  F.Hoffmann-La Roche Ltd, Basel, Switzerland  

International Consensus on Smoldering Disease in Multiple Sclerosis using the Delphi Method

Author:Bagnato, Francesca   Scalfari, Antonio   Oh, Jiwon   Airas, Laura   Bittner, Stefan   Calabrese, Massimiliano   Garcia Dominguez, Jose Manuel   Granziera, Cristina   Greenberg, Benjamin   Hellwig, Kerstin   Illes, Zsolt Laszlo   Lycke, Jan   Traboulsee, Anthony   Popescu, Veronica   Giovannoni, Gavin   

Session Name:P11: MS Neuroimaging 2  

Topic:MS and Inflammatory Disease  

Program Number:P11.013  

Author Institution:Vanderbilt University Medical Center, Nashville, TN  Imperial college, London, United Kingdom  St Michael's Hospital, Toronto, ON, Canada  University of Turku, Turku, Finland  Johannes Gutenberg- University, Mainz, Germany  Clinica Neurologica I, Padova, Italy  Hospital General Universitario Gregorio Marañón, Madrid, Spain  Basel University Hospital, Basel, Switzerland  UT Southwestern, Dallas, TX  St. Josef Hospital Bochum, Bochum, Germany  Odense University Hospital, Odense, Denmark  University of Gothenburg, Gothenburg, Sweden  University of British Columbia, Vancouver, BC, Canada  Noorderhart Hospital, Pelt, Belgium  QMUL, London, United Kingdom